EOLS Market Cap History



Below is a table of the EOLS market cap history going back to 2/8/2018:

Date EOLS Market Cap
2/8/2018271.32M
3/23/2018266.90M
5/10/2018271.86M
8/1/2018506.56M
11/1/2018420.58M
3/20/2019684.88M
4/26/2019775.16M
8/6/2019453.88M
12/31/2018681.91M
11/1/2019437.16M
2/21/2020345.04M
5/8/2020139.64M
8/5/2020111.71M
10/26/2020112.05M
3/25/2021554.98M
5/7/2021494.66M
8/2/2021612.89M
10/29/2021434.61M
2/28/2022509.60M
7/29/2022691.65M
11/4/2022426.91M
5/5/2023483.84M
7/28/2023577.12M
11/3/2023453.21M
3/1/2024863.94M
5/3/2024832.72M

Also see: EOLS Shares Outstanding History
and EOLS YTD Return
EOLS Historical Market Cap:
+19.71% CAGR
EOLS Historical Market Cap: +19.71% CAGR

Mouse over chart for data details
2/8/2018 ...5/3/2024
Evolus is a beauty company focused on delivering products in the self-pay aesthetic market. Co.'s commercial product is Jeuveau® (prabotulinumtoxinA-xvfs), a proprietary purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Co.'s primary market is the self-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications that are not reimbursed by any third-party payor, such as Medicaid, Medicare or commercial insurance. We show 26 historical shares outstanding datapoints in our EOLS shares outstanding history coverage, used to compute EOLS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EOLS market cap history over the course of time is important for investors interested in comparing EOLS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EOLS versus a peer is one thing; comparing EOLS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EOLS can fluctuate over the course of history. With this page we aim to empower investors researching EOLS by allowing them to research the EOLS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree EOLS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Evolus (EOLS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

EPZM Market Cap History
EQ Market Cap History
ERAS Market Cap History
ERNA Market Cap History
ESPR Market Cap History
ESRX Market Cap History
ETNB Market Cap History
ETON Market Cap History
ETTX Market Cap History
EVFM Market Cap History
More Healthcare companies »

 

EOLS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.